tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

ALRN

Aileron Therapeutics announces rebranding to Rein Therapeutics
The FlyAileron Therapeutics announces rebranding to Rein Therapeutics
11d ago
ALRN
Rein Therapeutics announces 2025 strategic objectives, anticipated milestones
PremiumThe Fly
Rein Therapeutics announces 2025 strategic objectives, anticipated milestones
11d ago
ALRN
Aileron Therapeutics Reports Q3 2024 Financial Results
PremiumCompany Announcements
Aileron Therapeutics Reports Q3 2024 Financial Results
2M ago
ALRN
Aileron reports results from Cohort 2 of its Phase 1b clinical trial of LTI-03
PremiumThe Fly
Aileron reports results from Cohort 2 of its Phase 1b clinical trial of LTI-03
2M ago
ALRN
Is ALRN a Buy, Before Earnings?
PremiumPre-Earnings
Is ALRN a Buy, Before Earnings?
3M ago
ALRN
Aileron Therapeutics’ ALRN-6924 to be acquired by Advancium Health Network
PremiumThe FlyAileron Therapeutics’ ALRN-6924 to be acquired by Advancium Health Network
3M ago
ALRN
Aileron completes enrollment of Cohort 2 of Phase 1b trial of LTI-03
Premium
The Fly
Aileron completes enrollment of Cohort 2 of Phase 1b trial of LTI-03
4M ago
ALRN
Aileron Therapeutics reports Q2 EPS (45c), one estimate (42c)
Premium
The Fly
Aileron Therapeutics reports Q2 EPS (45c), one estimate (42c)
5M ago
ALRN
Aileron Therapeutics to be included in Russell Microcap Index
PremiumThe Fly
Aileron Therapeutics to be included in Russell Microcap Index
7M ago
ALRN
Aileron Therapeutics initiated with a Buy at Brookline
PremiumThe Fly
Aileron Therapeutics initiated with a Buy at Brookline
8M ago
ALRN
Aileron Therapeutics Announces New Interim CFO Appointment
PremiumCompany Announcements
Aileron Therapeutics Announces New Interim CFO Appointment
8M ago
8K
ALRN
Aileron Therapeutics 4.27M share Direct Listing priced at $4.68
PremiumThe Fly
Aileron Therapeutics 4.27M share Direct Listing priced at $4.68
9M ago
ALRN
Aileron Therapeutics prices 4.27M shares at $4.68 in registered direct offering
PremiumThe FlyAileron Therapeutics prices 4.27M shares at $4.68 in registered direct offering
9M ago
ALRN
Aileron Therapeutics announces data from Cohort 1 of Phase 1b trial of LTI-03
Premium
The Fly
Aileron Therapeutics announces data from Cohort 1 of Phase 1b trial of LTI-03
9M ago
ALRN
Aileron Therapeutics price target raised to $19 from $9 at Ladenburg
Premium
The Fly
Aileron Therapeutics price target raised to $19 from $9 at Ladenburg
9M ago
ALRN
Aileron Therapeutics Announces CFO Transition and Appointment
PremiumCompany Announcements
Aileron Therapeutics Announces CFO Transition and Appointment
10M ago
8K
ALRN
Aileron Therapeutics Announces CEO Transition and Board Update
PremiumCompany Announcements
Aileron Therapeutics Announces CEO Transition and Board Update
10M ago
8K
ALRN
Aileron Therapeutics CEO Manuel Aivado steps down, Brian Windsor to succeed
PremiumThe Fly
Aileron Therapeutics CEO Manuel Aivado steps down, Brian Windsor to succeed
10M ago
ALRN
Aileron Therapeutics: Board Shake-Up and Nasdaq Compliance Success
PremiumCompany Announcements
Aileron Therapeutics: Board Shake-Up and Nasdaq Compliance Success
11M ago
8K
ALRN
Aileron Therapeutics’ Shareholders Approve Major Stock Proposals
PremiumCompany AnnouncementsAileron Therapeutics’ Shareholders Approve Major Stock Proposals
11M ago
8K
ALRN
Aileron Therapeutics Grants COO Performance Bonus for 2023
Premium
Company Announcements
Aileron Therapeutics Grants COO Performance Bonus for 2023
11M ago
8K
ALRN
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
12M ago
NBY
PTN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >